Pre-polycystic ovary syndrome and polymenorrhoea as new facets of polycystic ovary syndrome (PCOS): Evidences from a single centre data set

被引:4
|
作者
Ganie, Mohd Ashraf [1 ,2 ]
Rashid, Aafia [2 ]
Baba, Mohammad Salem [1 ]
Zargar, Mohd Afzal [3 ]
Wani, Imtiyaz Ahmad [2 ]
Nisar, Sobia [4 ]
Wani, Ishfaq Ahmad [2 ]
Douhath, Syed [2 ]
Sriwastawa, Mukesh [5 ]
Geer, Mohd Ishaq [6 ]
Asrar, Mir Mohd [2 ]
Kutum, Rintu [7 ,8 ]
Hassan, Saqib [9 ]
Khan, Shahid [10 ]
Rafi, Wajid [11 ]
Bhat, Dil Afroz [12 ]
Showkat, Wasia [2 ]
Sahar, Tajali [2 ]
Choh, Naseer Ahmad [13 ]
Khurshid, Rabia [14 ]
Mudassar, Syed [12 ]
Shah, Zafar Amin [15 ]
Shabir, Iram
Sofi, Sanjeed Ahmad [13 ]
Gupta, Nandita [11 ]
Hafeez, Imran [16 ,17 ]
Sreenivas, Vishnubatla [18 ]
机构
[1] Sheri Kashmir Inst Med Sci, Dept Endocrinol, Srinagar, India
[2] Sheri Kashmir Inst Med Sci, Dept Clin Res, Srinagar, India
[3] Cent Univ Kashmir, Dept Life Sci, Ganderbal, India
[4] Govt Med Coll, Dept Med, Srinagar, India
[5] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY USA
[6] Univ Kashmir, Dept Pharmacol, Srinagar, India
[7] Ashoka Univ, Dept Comp Sci, Sonepath, India
[8] Ashoka Univ, Trivedi Sch Biosci, Dept Comp Sci, Sonepath, India
[9] Deemed Univ, Sathyabama Inst Sci & Technol, Sch Bio & Chem Engn, Dept Biotechnol, Chennai, India
[10] AIIMS New Delhi, Dept Lab Med, New Delhi, India
[11] All India Inst Med Sci, Dept Endocrinol, New Delhi, India
[12] Sheri Kashmir Inst Med Sci, Dept Clin Biochem, Srinagar, India
[13] Sheri Kashmir Inst Med Sci, Dept Radiodiag & Imaging, Srinagar, India
[14] Sheri Kashmir Inst Med Sci, Dept Obstet & Gynecol, Srinagar, India
[15] Sheri Kashmir Inst Med Sci, Dept Immunol & Mol Med, Srinagar, India
[16] Iowa State Univ, Dept Biochem, Ames, IA USA
[17] Sheri Kashmir Inst Med Sci, Dept Cardiol, Srinagar, India
[18] All India Inst Med Sci, Dept Biostat, New Delhi, India
关键词
India; metabolism; oligomenorrhoea; PCOS; phenotype; polymenorrhoea; Pre-PCOS; INSULIN-RESISTANCE; METABOLIC SYNDROME; MENSTRUAL CYCLES; WOMEN; MORPHOLOGY; CRITERIA; SPIRONOLACTONE; ASSOCIATION; ADOLESCENTS; POPULATION;
D O I
10.1111/cen.14964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
ObjectivePolycystic ovary syndrome (PCOS) is a complex disorder with diverse metabolic implications. Diagnosis typically relies on oligo-amenorrhoea (OA), hyperandrogenism (HA), and polycystic ovarian morphology (PCOM). However, the role of polymenorrhoea in PCOS remains understudied. Additionally, limited information exists regarding metabolic disturbances in women with partial PCOS phenotypes that do not meet diagnostic criteria. This extensive database aims to provide substantial evidence on the metabolic implications of polymenorrhoea and partial PCOS phenotypes.DesignProspective observational study.Patients and MeasurementsIn this single-centre study, 6463 women with PCOS-like characteristics and 3142 age-matched healthy women were included. The study compared clinical (anthropometry, modified Ferriman Gallwey [mFG] score), hormonal (serum testosterone), and metabolic (plasma glucose, serum lipids, insulin) characteristics between women diagnosed with PCOS, those with partial PCOS phenotypes, and the healthy control groupResultsIn all, 5174 women met Rotterdam criteria for PCOS diagnosis, while 737 were classified as Pre-PCOS, including HA (n = 538), OA (n = 121), or PCOM (n = 78). Common clinical features included oligomenorrhoea (75.5%), hirsutism (82.9%), obesity (27.2%), hypertension (1.6%), metabolic syndrome (19.6%), and diabetes mellitus (5.6%). Women diagnosed with PCOS, HA only, and OA only exhibited higher average body mass index, plasma glucose levels (both fasting and 2 h after the oral glucose tolerance test), and lipid fractions in comparison to those with PCOM and the healthy controls. However, indices of insulin resistance were similar among women with PCOS, HA, PCOM, and OA, albeit higher than in the healthy controls. The polymenorrhoea subgroup (5.9%) had lower BMI and serum testosterone, but similar mFG score, plasma glucose, insulin, and lipid levels as the oligomenorrhoea subgroup.ConclusionThe metabolic disturbances observed in Pre-PCOS women highlight the need to reassess diagnostic criteria. Including the polymenorrhoea subcategory in PCOS criteria is recommended due to similar metabolic dysfunctions as the oligomenorrhoea group.
引用
收藏
页码:566 / 578
页数:13
相关论文
共 50 条
  • [31] Treatments targeting neuroendocrine dysfunction in polycystic ovary syndrome (PCOS)
    Garg, Akanksha
    Patel, Bijal
    Abbara, Ali
    Dhillo, Waljit S.
    CLINICAL ENDOCRINOLOGY, 2022, 97 (02) : 156 - 164
  • [32] Hyperinsulinism and polycystic ovary syndrome (PCOS): role of insulin clearance
    M. C. Amato
    R. Vesco
    E. Vigneri
    A. Ciresi
    C. Giordano
    Journal of Endocrinological Investigation, 2015, 38 : 1319 - 1326
  • [33] The Efficacy of Metformin and Exenatide in Polycystic Ovary Syndrome (PCOS) Patients
    Kesavan, Sanggeeta
    Akim, Abdah Md
    Chaudry, Gul-e-Saba
    Ranneh, Yazan K.
    ARS PHARMACEUTICA, 2023, 64 (02) : 100 - 122
  • [34] Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)
    Feichtinger M.
    Stopp T.
    Göbl C.
    Wiener Medizinische Wochenschrift, 2016, 166 (3-4) : 139 - 142
  • [35] Syndrom der polyzystischen Ovarien (PCOS)Polycystic ovary syndrome
    J.M. Weiss
    D. Hadžiomerović
    R. Kreienberg
    Der Gynäkologe, 2008, 41 (3): : 179 - 188
  • [36] Adiponectin levels in adolescent girls with polycystic ovary syndrome (PCOS)
    Pinhas-Hamiel, Orit
    Singer, Sigal
    Pilpel, Nurit
    Koren, Ilana
    Boyko, Valentina
    Hemi, Rina
    Pariente, Clara
    Kanety, Hannah
    CLINICAL ENDOCRINOLOGY, 2009, 71 (06) : 823 - 827
  • [37] Associations between Polycystic Ovary Syndrome (PCOS) and Antibiotic Use: Results from the UAEHFS
    Juber, Nirmin F.
    Abdulle, Abdishakur
    Ahmad, Amar
    AlAnouti, Fatme
    Loney, Tom
    Idaghdour, Youssef
    Valles, Yvonne
    Ali, Raghib
    ANTIBIOTICS-BASEL, 2024, 13 (05):
  • [38] Polycystic ovary syndrome (PCOS): progress towards a better understanding and treatment of the syndrome
    Mimouni, Nour El Houda
    Giacobini, Paolo
    COMPTES RENDUS BIOLOGIES, 2024, 347 : 19 - 25
  • [39] A New Predictor for Insulin Resistance in Polycystic Ovary Syndrome: InsuTAG
    Omma, Tulay
    Gokce, Aksanur
    Celik, Mustafa
    Karahan, Irfan
    Culha, Cavit
    Gulcelik, Nese Ersoz
    CURRENT WOMENS HEALTH REVIEWS, 2024, 20 (02)
  • [40] High Fat Diet and Polycystic Ovary Syndrome (PCOS) in Adolescence: An Overview of Nutritional Strategies
    Calcaterra, Valeria
    Magenes, Vittoria Carlotta
    Massini, Giulia
    De Sanctis, Luisa
    Fabiano, Valentina
    Zuccotti, Gianvincenzo
    NUTRIENTS, 2024, 16 (07)